Results 111 to 120 of about 881 (146)

Clinical Variables and Cell-Free DNA Fragmentomics: Biological and Clinical Insights

Clinical Chemistry
Yasine, Malki, Y M Dennis, Lo
openaire   +2 more sources

Diagnostic Accuracy of Blood-Based cfDNA/ctDNA Tests for Colorectal Cancer-A Systematic Review and Meta-Analysis. [PDF]

Cancers (Basel)
Rose JH, Mattikalli S, Bansal A, Jadhav RR, Song Y, Kunnackal John G, Gupta E.   +6 more
europepmc   +1 more source

Liquid biopsies for the diagnosis of early-stage gastric cancer: A 5-year systematic review. [PDF]

J Liq Biopsy
Papaioannou E, Ioannou D, Papamitsou T, Bobos M, Aivaliotis M, Psatha K, Karamitrousis E.   +6 more
europepmc   +1 more source

P125: Detection of pancreatic cancer in liquid biopsies using integrative fragmentomics

Genetics in Medicine Open
Dolev Rahat, Lilach Schneor, Noa Liscovitch-Brauer, Noam Shomron   +3 more
doaj   +1 more source

Liquid Biopsy in Advanced Prostate Cancer. [PDF]

Cancers (Basel)
Mediavilla-Medel P, García-Simón N, González-Del-Alba A, Romero A.   +3 more
europepmc   +1 more source

Genomics and Epigenomics Approaches for the Quantification of Circulating Tumor DNA in Liquid Biopsy: Relevance of a Multimodal Strategy. [PDF]

Int J Mol Sci
De Paolis E, Perrucci A, Albertini Petroni G, Conca A, Corsi M, Urbani A, Minucci A.   +6 more
europepmc   +1 more source

Liquid Biopsy in Gastrointestinal Cancers: Circulating Tumor DNA for Molecular Residual Disease Assessment and Early Treatment Monitoring. [PDF]

Cancers (Basel)
Safiejko K, Juchimiuk M, Pierko J, Maslyk M, Mucha M, Koda M, Konczuga-Koda L, Radej S, Akcakaya A, Szarpak L.   +9 more
europepmc   +1 more source

From multi-omics to deep learning: advances in cfDNA-based liquid biopsy for multi-cancer screening. [PDF]

Biomark Res
Luo X, Xie S, Hong F, Li X, Wei Y, Zhou Y, Su W, Yang Y, Tang L, Dao F, Cai P, Lin H, Lai H, Lyu H.   +13 more
europepmc   +1 more source

Circulating tumor DNA-guided early detection and minimal residual disease monitoring in pancreatic and biliary cancers: evidence, barriers, and opportunities. [PDF]

World J Surg Oncol
Liu R, Yang Y, Hu Z, Fu Y.
europepmc   +1 more source

Dissecting cell-free DNA fragmentation variation in tumors using cell line-derived xenograft mouse. [PDF]

PLoS One
Fu R, Su HA, Zhao Y, Tian Y, Chen H, Lu D.   +5 more
europepmc   +1 more source